Health Condition 1: C221- Intrahepatic bile duct carcinoma Health Condition 2: C220- Liver cell carcinoma Health Condition 3: C249- Malignant neoplasm of biliary tract, unspecified Health Condition 4: C251- Malignant neoplasm of body of pancreas Health Condition 5: C23- Malignant neoplasm of gallbladder Health Condition 6: C250- Malignant neoplasm of head of pancreas Health Condition 7: C229- Malignant neoplasm of liver, not specified as primary or secondary Health Condition 8: C228- Mali
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Age >18 years. 2) Able to give informed consent. 3) Able to communicate in Hindi/English/Marathi/Bengali. 4) Eastern Cooperative Oncology Group(ECOG) score �1.
Exclusion criteria
Exclusion criteria: 1)Patient planned for any disease directed treatment. 2)Patients with any pre-existing psychiatric disorder or intellectual disability.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparing Clinician predicted survival (CPS) versus Actual survival (AS) at the end of 90 days by calculating difference in days (temporal prediction), assessing percentage chance of survival (probabilistic prediction) at 48 hrs,7 days,30 days,60 days and 90 days and surprise question approach.Timepoint: Baseline evaluation | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparing predicted survival by PPI with CPS.Timepoint: Baseline evaluation;Comparing temporal prediction versus probabilistic prediction versus surprise question approach. Timepoint: Baseline evaluation;Patient or caregiver reported burden on Edmonton Symptom Assessment System- revised (ESAS-r).Timepoint: Baseline evaluation, 15 days, 30 days, 60 days, 90 days.;Using PPI as a prognostic tool and comparing it with Actual survival (AS).Timepoint: Baseline evaluation and at end of 90 days. | — |
Countries
India
Contacts
Tata Memorial Hopsital